These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 17289033

  • 21. Possible involvement of the expression and phosphorylation of N-Myc in the induction of HMGA1a by hypoxia in the human neuroblastoma cell line.
    Yanagita T, Manabe T, Okuda H, Matsuzaki S, Bando Y, Katayama T, Tohyama M.
    Neurosci Lett; 2005 Feb 01; 374(1):47-52. PubMed ID: 15631895
    [Abstract] [Full Text] [Related]

  • 22. Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells.
    Grandinetti KB, Spengler BA, Biedler JL, Ross RA.
    Oncogene; 2006 Feb 02; 25(5):706-12. PubMed ID: 16278682
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Biological evaluation of penetration domain and killing domain peptides.
    Jarajapu YP, Baltunis J, Knot HJ, Sullivan SM.
    J Gene Med; 2005 Jul 02; 7(7):908-17. PubMed ID: 15832372
    [Abstract] [Full Text] [Related]

  • 30. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC.
    Teye K, Okamoto K, Tanaka Y, Umata T, Ohnuma M, Moroi M, Kimura H, Tsuneoka M.
    Int J Oncol; 2008 Dec 02; 33(6):1271-80. PubMed ID: 19020761
    [Abstract] [Full Text] [Related]

  • 31. The ARF tumour suppressor.
    Gallagher SJ, Kefford RF, Rizos H.
    Int J Biochem Cell Biol; 2006 Dec 02; 38(10):1637-41. PubMed ID: 16600663
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. p19ARF directly and differentially controls the functions of c-Myc independently of p53.
    Qi Y, Gregory MA, Li Z, Brousal JP, West K, Hann SR.
    Nature; 2004 Oct 07; 431(7009):712-7. PubMed ID: 15361884
    [Abstract] [Full Text] [Related]

  • 36. Regulation of c-myc through intranuclear localization of its RNA subspecies.
    Shimizu N, Kawamoto JK, Utani K.
    Biochem Biophys Res Commun; 2007 Aug 03; 359(3):806-10. PubMed ID: 17560940
    [Abstract] [Full Text] [Related]

  • 37. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
    Alvaro-Blanco J, Martínez-Gac L, Calonge E, Rodríguez-Martínez M, Molina-Privado I, Redondo JM, Alcamí J, Flemington EK, Campanero MR.
    Carcinogenesis; 2009 Mar 03; 30(3):440-8. PubMed ID: 19126644
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. TP10, a delivery vector for decoy oligonucleotides targeting the Myc protein.
    El-Andaloussi S, Johansson H, Magnusdottir A, Järver P, Lundberg P, Langel U.
    J Control Release; 2005 Dec 10; 110(1):189-201. PubMed ID: 16253378
    [Abstract] [Full Text] [Related]

  • 40. p14 Arf promotes small ubiquitin-like modifier conjugation of Werners helicase.
    Woods YL, Xirodimas DP, Prescott AR, Sparks A, Lane DP, Saville MK.
    J Biol Chem; 2004 Nov 26; 279(48):50157-66. PubMed ID: 15355988
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.